FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 311:13-20 July 5, 1984 Number 1 Next

	Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited PubMed Citation

Abstract

Corticotropin-releasing factor, a hypophyseo-tropic hormone that stimulates adrenocorticotropic hormone (ACTH) secretion, has recently been isolated, characterized, and synthesized in the sheep and rat. We report on a patient with metastatic carcinoma of the prostate presenting with anterior and posterior pituitary hormone deficiency together with ACTH-dependent Cushing's syndrome. At postmortem examination, large areas of the median eminence and pituitary stalk were replaced by tumor, but the corticotrophs were markedly hyperplastic. Immunostaining of tumor cells was positive for corticotropin-releasing factor and was negative for ACTH and a wide range of other hormones. Radioimmunoassay and bioassays showed that tumor extracts and further purified fractions were active in corticotropin-releasing factor, and the tumor material coeluted with corticotropin-releasing factor on high-pressure liquid chromatography. These studies demonstrate that ectopic secretion of corticotropin-releasing factor is a cause of Cushing's syndrome in human beings. The features of this syndrome include hypercortisolism, pituitary corticotroph hyperplasia, elevation of circulating ACTH levels, and failure to suppress the pituitary-adrenal axis with exogenous glucocorticoids.

This article has been cited by other articles:

• Smart, J. L., Tolle, V., Otero-Corchon, V., Low, M. J. (2007). Central Dysregulation of the Hypothalamic-Pituitary-Adrenal Axis in Neuron-Specific Proopiomelanocortin-Deficient Mice. Endocrinology 148: 647-659 [Abstract] [Full Text]  
• Salgado, L. R., Fragoso, M. C. B V., Knoepfelmacher, M., Machado, M. C., Domenice, S., Pereira, M. A. A., de Mendonca, B. B. (2006). Ectopic ACTH syndrome: our experience with 25 cases.. Eur J Endocrinol 155: 725-733 [Abstract] [Full Text]  
• Heaney, A. P. (2006). Pituitary tumour pathogenesis.. Br Med Bull 75-76: 81-97 [Abstract] [Full Text]  
• Mohammad, H. P., Abbud, R. A., Parlow, A. F., Lewin, J. S., Nilson, J. H. (2003). Targeted Overexpression of Luteinizing Hormone Causes Ovary-Dependent Functional Adenomas Restricted to Cells of the Pit-1 Lineage. Endocrinology 144: 4626-4636 [Abstract] [Full Text]  
• Asa, S. L., Ezzat, S. (1998). The Cytogenesis and Pathogenesis of Pituitary Adenomas. Endocr. Rev. 19: 798-827 [Abstract] [Full Text]  
• Newell-Price, J., Trainer, P., Besser, M., Grossman, A. (1998). The Diagnosis and Differential Diagnosis of Cushing's Syndrome and Pseudo-Cushing's States. Endocr. Rev. 19: 647-672 [Abstract] [Full Text]  
• Shimon, I., Melmed, S. (1997). Pituitary Tumor Pathogenesis. J. Clin. Endocrinol. Metab. 82: 1675-1681 [Full Text]  
• Orth, D. N. (1995). Cushing's Syndrome. NEJM 332: 791-803 [Full Text]  
• Kreisberg, R. (1994). Half a Loaf. NEJM 330: 1295-1299 [Full Text]  
• Stein, R. C (1989). Nonmetastatic manifestations of malignancy: hormonal. Palliat Med 3: 189-196 [Abstract]